1. Home
  2. SLBT vs CGBD Comparison

SLBT vs CGBD Comparison

Compare SLBT & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$0.54

Market Cap

644.9M

Sector

N/A

ML Signal

N/A

CGBD

Carlyle Secured Lending Inc.

N/A

Current Price

$10.33

Market Cap

741.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SLBT
CGBD
Founded
N/A
2012
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
644.9M
741.7M
IPO Year
2025
2013

Fundamental Metrics

Financial Performance
Metric
SLBT
CGBD
Price
$0.54
$10.33
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
★ $12.21
AVG Volume (30 Days)
46.5K
★ 389.8K
Earning Date
10-26-2026
11-05-2026
Dividend Yield
N/A
★ 13.49%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.28
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.45
P/E Ratio
★ N/A
$37.05
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$9.95
52 Week High
$6.25
$13.28

Technical Indicators

Market Signals
Indicator
SLBT
CGBD
Relative Strength Index (RSI) 22.09 36.10
Support Level N/A $10.12
Resistance Level $1.75 $10.99
Average True Range (ATR) 0.13 0.30
MACD -0.01 -0.09
Stochastic Oscillator 4.94 0.82

Price Performance

Historical Comparison
SLBT
CGBD

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

About CGBD Carlyle Secured Lending Inc.

Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.

Share on Social Networks: